University Carlo Cattaneo

InterDigital and the University Carlos III of Madrid (UC3M) Formalize Wireless Research Partnership

Retrieved on: 
Thursday, October 12, 2023
European, Partnership, ISAC, Innovation, IMDEA Networks Institute, Communication, G, University Carlo Cattaneo, InterDigital, SNS, Research, History, UC3M, IDCC, EVP, Mobile phone

WILMINGTON, Del., Oct. 12, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, and the University Carlos III of Madrid (UC3M) have announced an expansion of their bilateral partnership in research to enable technologies that enhance future wireless networks.

Key Points: 
  • WILMINGTON, Del., Oct. 12, 2023 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, and the University Carlos III of Madrid (UC3M) have announced an expansion of their bilateral partnership in research to enable technologies that enhance future wireless networks.
  • The InterDigital and UC3M partnership reflects an important research collaboration at a time when 6G research and standardization has emerged as a priority across the European Union, United States, and other regions worldwide.
  • InterDigital has won five of these projects and continues to collaborate with research institutions to bolster the research.
  • With a history of partnership in Europe spanning more than a decade, InterDigital recognizes Spain and the European Union’s importance in the global 6G wireless research and standards ecosystem.

Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer

Retrieved on: 
Thursday, October 5, 2023
Senior, Knowledge, SEK, MBA, Physician, Nasdaq Stockholm, Research, Development, School, MD, Vanderbilt University School of Medicine, Medical Affairs Bureau, University, University Carlo Cattaneo, University of Valencia, Novo Nordisk, RDMA, Rare, Patient, Management, Pharmaceutical industry, Fine chemical, Swedish Orphan Biovitrum

STOCKHOLM, Oct. 5, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced the appointment of Lydia Abad-Franch, MD, MBA as Senior Vice President, Head of Research, Development and Medical Affairs (RDMA), and Chief Medical Officer.

Key Points: 
  • STOCKHOLM, Oct. 5, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced the appointment of Lydia Abad-Franch, MD, MBA as Senior Vice President, Head of Research, Development and Medical Affairs (RDMA), and Chief Medical Officer.
  • "Lydia is both an accomplished leader in rare diseases and an esteemed practicing medical doctor," said Guido Oelkers, CEO of Sobi.
  • "In addition, she has deep knowledge of the Sobi business as she has been with us for almost four years.
  • Lydia Abad-Franch said: "I am very excited to lead the research, development, and medical teams at Sobi, where we have a strong portfolio of transformative medicines for people with rare diseases.